Sirtuins in kidney health and disease
Guarente, L. & Franklin, H. Epstein lecture: sirtuins, aging, and medicine. N. Engl. J. Med. 364, 2235–2244 (2011).
Google Scholar
Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795–800 (2000).
Google Scholar
Tissenbaum, H. A. & Guarente, L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227–230 (2001).
Google Scholar
Rogina, B. & Helfand, S. L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl Acad. Sci. USA 101, 15998–16003 (2004).
Google Scholar
Kanfi, Y. et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 483, 218–221 (2012).
Google Scholar
Burnett, C. et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482–485 (2011).
Google Scholar
Satoh, A. et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 18, 416–430 (2013).
Google Scholar
Benigni, A. et al. Sirt3 deficiency shortens life span and impairs cardiac mitochondrial function rescued by Opa1 gene transfer. Antioxid. Redox Signal. 31, 1255–1271 (2019).
Google Scholar
Mostoslavsky, R. et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315–329 (2006).
Google Scholar
Yuan, H. & Marmorstein, R. Structural basis for sirtuin activity and inhibition. J. Biol. Chem. 287, 42428–42435 (2012).
Google Scholar
Kiran, S. et al. Intracellular distribution of human SIRT7 and mapping of the nuclear/nucleolar localization signal. FEBS J. 280, 3451–3466 (2013).
Google Scholar
Tanner, K. G., Landry, J., Sternglanz, R. & Denu, J. M. Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl Acad. Sci. USA 97, 14178–14182 (2000).
Google Scholar
Vaquero, A. et al. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell 16, 93–105 (2004).
Google Scholar
Jin, Q. et al. Cytoplasm-localized SIRT1 enhances apoptosis. J. Cell Physiol. 213, 88–97 (2007).
Google Scholar
Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K. & Horio, Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 282, 6823–6832 (2007).
Google Scholar
Li, Y., Xu, W., McBurney, M. W. & Longo, V. D. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab. 8, 38–48 (2008).
Google Scholar
Hisahara, S. et al. Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc. Natl Acad. Sci. USA 105, 15599–15604 (2008).
Google Scholar
Tennen, R. I. & Chua, K. F. Chromatin regulation and genome maintenance by mammalian SIRT6. Trends Biochem. Sci. 36, 39–46 (2011).
Google Scholar
Tsai, Y.-C., Greco, T. M., Boonmee, A., Miteva, Y. & Cristea, I. M. Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Mol. Cell. Proteom. 11, 60–76 (2012).
Google Scholar
Dryden, S. C., Nahhas, F. A., Nowak, J. E., Goustin, A.-S. & Tainsky, M. A. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol. 23, 3173–3185 (2003).
Google Scholar
Nekooki-Machida, Y. & Hagiwara, H. Role of tubulin acetylation in cellular functions and diseases. Med. Mol. Morphol. 53, 191–197 (2020).
Google Scholar
Serrano, L. et al. The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes. Dev. 27, 639–653 (2013).
Google Scholar
North, B. J. et al. SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO J. 33, 1438–1453 (2014).
Google Scholar
Baeza, J., Smallegan, M. J. & Denu, J. M. Mechanisms and dynamics of protein acetylation in mitochondria. Trends Biochem. Sci. 41, 231–244 (2016).
Google Scholar
Lombard, D. B. et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 27, 8807–8814 (2007).
Google Scholar
Iwahara, T., Bonasio, R., Narendra, V. & Reinberg, D. SIRT3 functions in the nucleus in the control of stress-related gene expression. Mol. Cell. Biol. 32, 5022–5034 (2012).
Google Scholar
Zhang, X. et al. Molecular basis for hierarchical histone de-β-hydroxybutyrylation by SIRT3. Cell Discov. 5, 35 (2019).
Google Scholar
Scher, M. B., Vaquero, A. & Reinberg, D. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes. Dev. 21, 920–928 (2007).
Google Scholar
Guarente, L. Calorie restriction and sirtuins revisited. Genes. Dev. 27, 2072–2085 (2013).
Google Scholar
Nakagawa, T., Lomb, D. J., Haigis, M. C. & Guarente, L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560–570 (2009).
Google Scholar
Du, J. et al. Sirt5 is an NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806–809 (2011).
Google Scholar
Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225–238 (2012).
Google Scholar
Ahn, B.-H. et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl Acad. Sci. USA 105, 14447–14452 (2008).
Google Scholar
Finley, L. W. S. et al. Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS One 6, e23295 (2011).
Google Scholar
Rahman, M. et al. Drosophila Sirt2/mammalian SIRT3 deacetylates ATP synthase β and regulates complex V activity. J. Cell Biol. 206, 289–305 (2014).
Google Scholar
Yang, Y. et al. NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J. Biol. Chem. 285, 7417–7429 (2010).
Google Scholar
Dittenhafer-Reed, K. E. et al. SIRT3 mediates multi-tissue coupling for metabolic fuel switching. Cell Metab. 21, 637–646 (2015).
Google Scholar
Hirschey, M. D. et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121–125 (2010).
Google Scholar
Shimazu, T. et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12, 654–661 (2010).
Google Scholar
Picard, F. et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429, 771–776 (2004).
Google Scholar
Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434, 113–118 (2005).
Google Scholar
Frescas, D., Valenti, L. & Accili, D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 280, 20589–20595 (2005).
Google Scholar
Zhong, L. et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α. Cell 140, 280–293 (2010).
Google Scholar
Lee, Y. et al. Myeloid sirtuin 6 deficiency causes insulin resistance in high-fat diet-fed mice by eliciting macrophage polarization toward an M1 phenotype. Diabetes 66, 2659–2668 (2017).
Google Scholar
Zhan, M., Brooks, C., Liu, F., Sun, L. & Dong, Z. Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int. 83, 568–581 (2013).
Google Scholar
Zhang, Q. et al. Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin-induced myocardial injury. Cancer Innov. 2, 253–264 (2023).
Google Scholar
Samant, S. A. et al. SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol. Cell. Biol. 34, 807–819 (2014).
Google Scholar
Morigi, M. et al. Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J. Clin. Invest. 125, 715–726 (2015).
Google Scholar
Chen, Z. et al. Sirt6 deficiency contributes to mitochondrial fission and oxidative damage in podocytes via ROCK1-Drp1 signalling pathway. Cell Prolif. 55, e13296 (2022).
Google Scholar
Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115–124 (1999).
Google Scholar
Dominy, J. E. et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol. Cell 48, 900–913 (2012).
Google Scholar
Xin, T. & Lu, C. SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury. Aging 12, 16224–16237 (2020).
Google Scholar
Wan, W. et al. Regulation of mitophagy by sirtuin family proteins: a vital role in aging and age-related diseases. Front. Aging Neurosci. 14, 845330 (2022).
Google Scholar
Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q. & Griendling, K. K. Reactive oxygen species in metabolic and inflammatory signaling. Circ. Res. 122, 877–902 (2018).
Google Scholar
Ogura, Y., Kitada, M. & Koya, D. Sirtuins and renal oxidative stress. Antioxidants 10, 1198 (2021).
Google Scholar
Wu, Q.-J. et al. The sirtuin family in health and disease. Signal. Transduct. Target. Ther. 7, 402 (2022).
Google Scholar
He, F., Ru, X. & Wen, T. NRF2, a transcription factor for stress response and beyond. Int. J. Mol. Sci. 21, 4777 (2020).
Google Scholar
Chen, Y. et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 12, 534–541 (2011).
Google Scholar
Xu, Y. et al. Studies on the regulatory mechanism of isocitrate dehydrogenase 2 using acetylation mimics. Sci. Rep. 7, 9785 (2017).
Google Scholar
Alves-Fernandes, D. K. & Jasiulionis, M. G. The role of SIRT1 on DNA damage response and epigenetic alterations in cancer. Int. J. Mol. Sci. 20, 3153 (2019).
Google Scholar
Meng, F. et al. Synergy between SIRT1 and SIRT6 helps recognize DNA breaks and potentiates the DNA damage response and repair in humans and mice. eLife 9, e55828 (2020).
Google Scholar
Jeong, J. et al. SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp. Mol. Med. 39, 8–13 (2007).
Google Scholar
Kume, S. et al. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free. Radic. Biol. Med. 40, 2175–2182 (2006).
Google Scholar
Kume, S. et al. SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J. Biol. Chem. 282, 151–158 (2007).
Google Scholar
Chuang, P. Y. et al. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One 6, e23566 (2011).
Google Scholar
Jiao, X., Li, Y., Zhang, T., Liu, M. & Chi, Y. Role of Sirtuin3 in high glucose-induced apoptosis in renal tubular epithelial cells. Biochem. Biophys. Res. Commun. 480, 387–393 (2016).
Google Scholar
Liu, M. et al. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat. Commun. 8, 413 (2017).
Google Scholar
Guo, H. & Bechtel-Walz, W. The interplay of autophagy and oxidative stress in the kidney: what do we know? Nephron 147, 627–642 (2023).
Google Scholar
Lee, I. H. Mechanisms and disease implications of sirtuin-mediated autophagic regulation. Exp. Mol. Med. 51, 1–11 (2019).
Google Scholar
Lee, I. H. et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl Acad. Sci. USA 105, 3374–3379 (2008).
Google Scholar
Chun, S. K. et al. Loss of sirtuin 1 and mitofusin 2 contributes to enhanced ischemia/reperfusion injury in aged livers. Aging Cell 17, e12761 (2018).
Google Scholar
Wang, Y., Chang, J., Wang, Z.-Q. & Li, Y. Sirt3 promotes the autophagy of HK-2 human proximal tubular epithelial cells via the inhibition of Notch-1/Hes-1 signaling. Mol. Med. Rep. 24, 634 (2021).
Google Scholar
Li, R. et al. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy. Redox Biol. 18, 229–243 (2018).
Google Scholar
Takasaka, N. et al. Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence. J. Immunol. 192, 958–968 (2014).
Google Scholar
Xu, C. et al. SIRT1 is downregulated by autophagy in senescence and ageing. Nat. Cell Biol. 22, 1170–1179 (2020).
Google Scholar
Lee, S.-H., Lee, J.-H., Lee, H.-Y. & Min, K.-J. Sirtuin signaling in cellular senescence and aging. BMB Rep. 52, 24–34 (2019).
Google Scholar
Hayakawa, T. et al. SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation. PLoS One 10, e0116480 (2015).
Google Scholar
Huang, J. et al. SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS One 3, e1710 (2008).
Google Scholar
Zu, Y. et al. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ. Res. 106, 1384–1393 (2010).
Google Scholar
Grootaert, M. O. J., Finigan, A., Figg, N. L., Uryga, A. K. & Bennett, M. R. SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis. Circ. Res. 128, 474–491 (2021).
Google Scholar
Zhao, G. et al. SIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation. Aging 8, 2308–2323 (2016).
Google Scholar
Diao, Z. et al. SIRT3 consolidates heterochromatin and counteracts senescence. Nucleic Acids Res. 49, 4203–4219 (2021).
Google Scholar
Ma, C. et al. Sirt3 attenuates oxidative stress damage and rescues cellular senescence in rat bone marrow mesenchymal stem cells by targeting superoxide dismutase 2. Front. Cell Dev. Biol. 8, 599376 (2020).
Google Scholar
Fan, X. et al. Sirt3 activates autophagy to prevent DOX-induced senescence by inactivating PI3K/AKT/mTOR pathway in A549 cells. Biochim. Biophys. Acta Mol. Cell Res. 1870, 119411 (2023).
Google Scholar
Gómez, H. Reprogramming metabolism to enhance kidney tolerance during sepsis: the role of fatty acid oxidation, aerobic glycolysis, and epithelial de-differentiation. Nephron 147, 31–34 (2023).
Google Scholar
Vachharajani, V. T. et al. Sirtuins link inflammation and metabolism. J. Immunol. Res. 2016, 8167273 (2016).
Google Scholar
Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K. & Salminen, A. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell. Signal. 25, 1939–1948 (2013).
Google Scholar
Rabadi, M. M. et al. High-mobility group box 1 is a novel deacetylation target of Sirtuin1. Kidney Int. 87, 95–108 (2015).
Google Scholar
Labiner, H. E., Sas, K. M., Baur, J. A. & Sims, C. A. Sirtuin 1 deletion increases inflammation and mortality in sepsis. J. Trauma. Acute Care Surg. 93, 672–678 (2022).
Google Scholar
Zhao, W.-Y., Zhang, L., Sui, M.-X., Zhu, Y.-H. & Zeng, L. Protective effects of sirtuin 3 in a murine model of sepsis-induced acute kidney injury. Sci. Rep. 6, 33201 (2016).
Google Scholar
Zhang, W. et al. An immune atlas of nephrolithiasis: single-cell mass cytometry on SIRT3 knockout and calcium oxalate-induced renal injury. J. Immunol. Res. 2021, 1260140 (2021).
Google Scholar
Doke, T. et al. NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury. Nat. Metab. 5, 414–430 (2023).
Google Scholar
Pantaleon, M. & Kaye, P. L. Glucose transporters in preimplantation development. Rev. Reprod. 3, 77–81 (1998).
Google Scholar
Ochocki, J. D. & Simon, M. C. Nutrient-sensing pathways and metabolic regulation in stem cells. J. Cell Biol. 203, 23–33 (2013).
Google Scholar
Chevalier, R. L. Bioenergetic evolution explains prevalence of low nephron number at birth: risk factor for CKD. Kidney360 1, 863–879 (2020).
Google Scholar
Mandal, S., Lindgren, A. G., Srivastava, A. S., Clark, A. T. & Banerjee, U. Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells. Stem Cell 29, 486–495 (2011).
Google Scholar
Chung, S. et al. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat. Clin. Pract. Cardiovasc. Med. 4, S60–S67 (2007).
Google Scholar
Folmes, C. D. L. & Terzic, A. Metabolic determinants of embryonic development and stem cell fate. Reprod. Fertil. Dev. 27, 82–88 (2014).
Google Scholar
Liu, J. et al. Regulation of nephron progenitor cell self-renewal by intermediary metabolism. J. Am. Soc. Nephrol. 28, 3323–3335 (2017).
Google Scholar
Perico, L. et al. Post-translational modifications by SIRT3 de-2-hydroxyisobutyrylase activity regulate glycolysis and enable nephrogenesis. Sci. Rep. 11, 23580 (2021).
Google Scholar
Pezzotta, A. et al. Low nephron number induced by maternal protein restriction is prevented by nicotinamide riboside supplementation depending on sirtuin 3 activation. Cells 11, 3316 (2022).
Google Scholar
Luyckx, V. A. & Brenner, B. M. Birth weight, malnutrition and kidney-associated outcomes — a global concern. Nat. Rev. Nephrol. 11, 135–149 (2015).
Google Scholar
Erichsen, L. & Adjaye, J. Crosstalk between age accumulated DNA-damage and the SIRT1-AKT-GSK3ß axis in urine derived renal progenitor cells. Aging 14, 8179–8204 (2022).
Google Scholar
Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 3, 629–646 (2017).
Google Scholar
Haschler, T. N. et al. Sirtuin 5 depletion impairs mitochondrial function in human proximal tubular epithelial cells. Sci. Rep. 11, 15510 (2021).
Google Scholar
Chiba, T. et al. Sirtuin 5 regulates proximal tubule fatty acid oxidation to protect against AKI. J. Am. Soc. Nephrol. 30, 2384–2398 (2019).
Google Scholar
Ozawa, S. et al. Glycolysis, but not mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes. Sci. Rep. 5, 18575 (2015).
Google Scholar
Perico, L., Conti, S., Benigni, A. & Remuzzi, G. Podocyte-actin dynamics in health and disease. Nat. Rev. Nephrol. 12, 692–710 (2016).
Google Scholar
Tsai, Y.-C. et al. Upregulating sirtuin 6 ameliorates glycolysis, EMT and distant metastasis of pancreatic adenocarcinoma with krüppel-like factor 10 deficiency. Exp. Mol. Med. 53, 1623–1635 (2021).
Google Scholar
Huang, W. et al. Sirt6 deficiency results in progression of glomerular injury in the kidney. Aging 9, 1069–1083 (2017).
Google Scholar
Zhang, D., Li, S., Cruz, P. & Kone, B. C. Sirtuin 1 functionally and physically interacts with disruptor of telomeric silencing-1 to regulate alpha-ENaC transcription collecting duct. J. Biol. Chem. 284, 20917–20926 (2009).
Google Scholar
Yang, S.-Y. et al. A low-salt diet increases the expression of renal sirtuin 1 through activation of the ghrelin receptor in rats. Sci. Rep. 6, 32787 (2016).
Google Scholar
Noriega, L. G. et al. SIRT7 modulates the stability and activity of the renal K-Cl cotransporter KCC4 through deacetylation. EMBO Rep. 22, e50766 (2021).
Google Scholar
Mercado, A. et al. The K+:Cl− cotransporter KCC4 is activated by deacetylation induced by the sirtuin7 (SIRT7). FASEB J. 29, 666.24 (2015).
Google Scholar
Mattagajasingh, I. et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 104, 14855–14860 (2007).
Google Scholar
Dioum, E. M. et al. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 324, 1289–1293 (2009).
Google Scholar
Potente, M. et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes. Dev. 21, 2644–2658 (2007).
Google Scholar
Pezzotta, A. et al. Sirt3 deficiency promotes endothelial dysfunction and aggravates renal injury. PLoS One 18, e0291909 (2023).
Google Scholar
Ho, K. M. & Morgan, D. J. R. The proximal tubule as the pathogenic and therapeutic target in acute kidney injury. Nephron 146, 494–502 (2022).
Google Scholar
Koehler, F. C., Späth, M. R., Hoyer-Allo, K. J. R. & Müller, R.-U. Mechanisms of caloric restriction-mediated stress-resistance in acute kidney injury. Nephron 146, 234–238 (2022).
Google Scholar
Hasegawa, K. et al. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J. Biol. Chem. 285, 13045–13056 (2010).
Google Scholar
Funk, J. A. & Schnellmann, R. G. Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury. Toxicol. Appl. Pharmacol. 273, 345–354 (2013).
Google Scholar
Fan, H. et al. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int. 83, 404–413 (2013).
Google Scholar
Han, S. et al. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway. Int. Immunopharmacol. 99, 108022 (2021).
Google Scholar
He, S. et al. NAD+ ameliorates endotoxin-induced acute kidney injury in a sirtuin1-dependent manner via GSK-3β/Nrf2 signalling pathway. J. Cell. Mol. Med. 26, 1979–1993 (2022).
Google Scholar
Zhang, J., Yang, S., Chen, F., Li, H. & Chen, B. Ginkgetin aglycone ameliorates LPS-induced acute kidney injury by activating SIRT1 via inhibiting the NF-κB signaling pathway. Cell Biosci. 7, 44 (2017).
Google Scholar
Lempiäinen, J., Finckenberg, P., Levijoki, J. & Mervaala, E. AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney. Br. J. Pharmacol. 166, 1905–1915 (2012).
Google Scholar
Gan, Y., Tao, S., Cao, D., Xie, H. & Zeng, Q. Protection of resveratrol on acute kidney injury in septic rats. Hum. Exp. Toxicol. 36, 1015–1022 (2017).
Google Scholar
Li, Z. et al. Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling. Kidney Int. 93, 881–892 (2018).
Google Scholar
Miao, J. et al. Sirtuin 6 is a key contributor to gender differences in acute kidney injury. Cell Death Discov. 9, 134 (2023).
Google Scholar
Jian, Y. et al. Sirt3 mitigates LPS-induced mitochondrial damage in renal tubular epithelial cells by deacetylating YME1L1. Cell Prolif. 56, e13362 (2023).
Google Scholar
Shen, L., Zhang, Q., Tu, S. & Qin, W. SIRT3 mediates mitofusin 2 ubiquitination and degradation to suppress ischemia reperfusion-induced acute kidney injury. Exp. Cell Res. 408, 112861 (2021).
Google Scholar
Brooks, C., Wei, Q., Cho, S.-G. & Dong, Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Invest. 119, 1275–1285 (2009).
Google Scholar
Ugur, S. et al. The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity. Ren. Fail. 37, 332–336 (2015).
Google Scholar
Zhao, L. et al. Protective effect of the total flavonoids from Rosa laevigata Michx fruit on renal ischemia-reperfusion injury through suppression of oxidative stress and inflammation. Molecules 21, 952 (2016).
Google Scholar
Li, Y. et al. Activation of sirtuin 3 by silybin attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury. Front. Pharmacol. 8, 178 (2017).
Google Scholar
Xu, S. et al. SIRT1/3 activation by resveratrol attenuates acute kidney injury in a septic rat model. Oxid. Med. Cell. Longev. 2016, 7296092 (2016).
Google Scholar
Pan, J. S.-C. et al. Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway. J. Am. Soc. Nephrol. 26, 364–378 (2015).
Google Scholar
Perico, L. et al. Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function. Nat. Commun. 8, 983 (2017).
Google Scholar
Miyasato, Y. et al. Sirtuin 7 deficiency ameliorates cisplatin-induced acute kidney injury through regulation of the inflammatory response. Sci. Rep. 8, 5927 (2018).
Google Scholar
Sánchez-Navarro, A. et al. Sirtuin 7 deficiency reduces inflammation and tubular damage induced by an episode of acute kidney injury. Int. J. Mol. Sci. 23, 2573 (2022).
Google Scholar
Poyan Mehr, A. et al. De novo NAD+ biosynthetic impairment in acute kidney injury in humans. Nat. Med. 24, 1351–1359 (2018).
Google Scholar
Katsyuba, E. et al. De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature 563, 354–359 (2018).
Google Scholar
Cortinovis, M., Perico, N., Ruggenenti, P., Remuzzi, A. & Remuzzi, G. Glomerular hyperfiltration. Nat. Rev. Nephrol. 18, 435–451 (2022).
Google Scholar
Kitada, M., Kume, S., Takeda-Watanabe, A., Kanasaki, K. & Koya, D. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin. Sci. 124, 153–164 (2013).
Google Scholar
Lagouge, M. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127, 1109–1122 (2006).
Google Scholar
Baur, J. A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337–342 (2006).
Google Scholar
Zoja, C., Xinaris, C. & Macconi, D. Diabetic nephropathy: novel molecular mechanisms and therapeutic targets. Front. Pharmacol. 11, 586892 (2020).
Google Scholar
Yasuda, I. et al. Pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic nephropathy. J. Am. Soc. Nephrol. 32, 1355–1370 (2021).
Google Scholar
Hasegawa, K. et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat. Med. 19, 1496–1504 (2013).
Google Scholar
Yubero-Serrano, E. M. et al. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease. Clin. J. Am. Soc. Nephrol. 10, 759–766 (2015).
Google Scholar
Fan, Y. et al. Sirt6 suppresses high glucose-induced mitochondrial dysfunction and apoptosis in podocytes through AMPK activation. Int. J. Biol. Sci. 15, 701–713 (2019).
Google Scholar
Wang, X., Ji, T., Li, X., Qu, X. & Bai, S. FOXO3a protects against kidney injury in type II diabetic nephropathy by promoting Sirt6 expression and inhibiting Smad3 acetylation. Oxid. Med. Cell. Longev. 2021, 5565761 (2021).
Google Scholar
Liu, J. et al. CircRNA circ-ITCH improves renal inflammation and fibrosis in streptozotocin-induced diabetic mice by regulating the miR-33a-5p/SIRT6 axis. Inflamm. Res. 70, 835–846 (2021).
Google Scholar
Muraoka, H. et al. Role of Nampt-Sirt6 axis in renal proximal tubules in extracellular matrix deposition in diabetic nephropathy. Cell Rep. 27, 199–212.e5 (2019).
Google Scholar
Ji, L. et al. Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy. Int. J. Oncol. 55, 103–115 (2019).
Google Scholar
Locatelli, M. et al. Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes. Sci. Rep. 10, 8418 (2020).
Google Scholar
Wang, X. X. et al. G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J. Am. Soc. Nephrol. 27, 1362–1378 (2016).
Google Scholar
Locatelli, M. et al. Sirtuin 3 deficiency aggravates kidney disease in response to high-fat diet through lipotoxicity-induced mitochondrial damage. Int. J. Mol. Sci. 23, 8345 (2022).
Google Scholar
Zhou, Y. et al. Metrnl alleviates lipid accumulation by modulating mitochondrial homeostasis in diabetic nephropathy. Diabetes 72, 611–626 (2023).
Google Scholar
Macconi, D., Remuzzi, G. & Benigni, A. Key fibrogenic mediators: old players. Renin-angiotensin system. Kidney Int. Suppl. 4, 58–64 (2014).
Google Scholar
Liu, X. et al. Impaired nicotinamide adenine dinucleotide biosynthesis in the kidney of chronic kidney disease. Front. Physiol. 12, 723690 (2021).
Google Scholar
Zhang, Y. et al. Sirtuin 1 activation reduces transforming growth factor-β1-induced fibrogenesis and affords organ protection in a model of progressive, experimental kidney and associated cardiac disease. Am. J. Pathol. 187, 80–90 (2017).
Google Scholar
He, W. et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J. Clin. Invest. 120, 1056–1068 (2010).
Google Scholar
Simic, P. et al. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis. Cell Rep. 3, 1175–1186 (2013).
Google Scholar
Huang, X.-Z. et al. Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway. J. Cell. Biochem. 115, 996–1005 (2014).
Google Scholar
Vasko, R. et al. Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14: relevance to fibrosis of vascular senescence. J. Am. Soc. Nephrol. 25, 276–291 (2014).
Google Scholar
Kida, Y., Zullo, J. A. & Goligorsky, M. S. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation. Biochem. Biophys. Res. Commun. 478, 1074–1079 (2016).
Google Scholar
Li, P. et al. SIRT1 attenuates renal fibrosis by repressing HIF-2α. Cell Death Discov. 7, 59 (2021).
Google Scholar
Lipphardt, M., Dihazi, H., Müller, G. A. & Goligorsky, M. S. Fibrogenic secretome of sirtuin 1-deficient endothelial cells: Wnt, notch and glycocalyx rheostat. Front. Physiol. 9, 1325 (2018).
Google Scholar
Cai, J. et al. The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression. Kidney Int. 97, 106–118 (2020).
Google Scholar
Li, X., Li, W., Zhang, Z., Wang, W. & Huang, H. SIRT6 overexpression retards renal interstitial fibrosis through targeting HIPK2 in chronic kidney disease. Front. Pharmacol. 13, 1007168 (2022).
Google Scholar
Cai, J. et al. Phosphorylation by GSK-3β increases the stability of SIRT6 to alleviate TGF-β-induced fibrotic response in renal tubular cells. Life Sci. 308, 120914 (2022).
Google Scholar
Benigni, A., Perico, L. & Macconi, D. Mitochondrial dynamics is linked to longevity and protects from end-organ injury: the emerging role of sirtuin 3. Antioxid. Redox Signal. 25, 185–199 (2016).
Google Scholar
Sundaresan, N. R. et al. SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3β. Mol. Cell. Biol. 36, 678–692 (2015).
Google Scholar
Cheng, L. et al. SIRT3 deficiency exacerbates early-stage fibrosis after ischaemia-reperfusion-induced AKI. Cell. Signal. 93, 110284 (2022).
Google Scholar
Zhang, Y. et al. Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis. Cell Death Dis. 12, 847 (2021).
Google Scholar
Quan, Y. et al. Sirtuin 3 activation by honokiol decreases unilateral ureteral obstruction-induced renal inflammation and fibrosis via regulation of mitochondrial dynamics and the renal NF-κB-TGF-β1/Smad signaling pathway. Int. J. Mol. Sci. 21, 402 (2020).
Google Scholar
Li, N. et al. SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension. Oncotarget 8, 39592–39604 (2017).
Google Scholar
Srivastava, S. P. et al. Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys. iScience 24, 102390 (2021).
Google Scholar
The EMPA-KIDNEY Collaborative Group. Empagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 388, 117–127 (2023).
Google Scholar
Wang, Z. et al. Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress. Biochem. Biophys. Res. Commun. 653, 53–61 (2023).
Google Scholar
Packer, M. Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling/autophagy hypothesis. Circulation 146, 1383–1405 (2022).
Google Scholar
Li, W. et al. SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 chronic kidney disease. J. Clin. Invest. 132, e150051 (2022).
Google Scholar
Badi, I. et al. miR-34a promotes vascular smooth muscle cell calcification by downregulating SIRT1 (Sirtuin 1) and Axl (AXL receptor tyrosine kinase). Arterioscler. Thromb. Vasc. Biol. 38, 2079–2090 (2018).
Google Scholar
Liu, X. et al. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway. Aging Cell 20, e13377 (2021).
Google Scholar
Liu, S.-M. et al. Intermedin alleviates vascular calcification in CKD through sirtuin 3-mediated inhibition of mitochondrial oxidative stress. Pharmaceuticals 15, 1224 (2022).
Google Scholar
Ong, A. C. M., Devuyst, O., Knebelmann, B. & Walz, G. & ERA-EDTA Working Group for Inherited Kidney Diseases. Autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet 385, 1993–2002 (2015).
Google Scholar
Zhou, X. et al. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J. Clin. Invest. 123, 3084–3098 (2013).
Google Scholar
El Ters, M. et al. Biological efficacy and safety of niacinamide in patients with ADPKD. Kidney Int. Rep. 5, 1271–1279 (2020).
Google Scholar
Shen, P. et al. SIRT1: a potential therapeutic target in autoimmune diseases. Front. Immunol. 12, 779177 (2021).
Google Scholar
Olivares, D. et al. Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis. Clin. Sci. 132, 569–579 (2018).
Google Scholar
Consiglio, C. R. et al. SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus. Mol. Biol. Rep. 41, 4233–4239 (2014).
Google Scholar
Hu, N., Long, H., Zhao, M., Yin, H. & Lu, Q. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Scand. J. Rheumatol. 38, 464–471 (2009).
Google Scholar
Gan, H. et al. B cell Sirt1 deacetylates histone and non-histone proteins for epigenetic modulation of AID expression and the antibody response. Sci. Adv. 6, eaay2793 (2020).
Google Scholar
Guan, Y. et al. Nicotinamide mononucleotide, an NAD+ precursor, rescues age-associated susceptibility to AKI in a sirtuin 1-dependent manner. J. Am. Soc. Nephrol. 28, 2337–2352 (2017).
Google Scholar
Kume, S. et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. 120, 1043–1055 (2010).
Google Scholar
Chuang, P. Y. et al. Reduction in podocyte SIRT1 accelerates kidney injury in aging mice. Am. J. Physiol. Renal Physiol. 313, F621–F628 (2017).
Google Scholar
Chen, J. et al. Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am. J. Pathol. 180, 973–983 (2012).
Google Scholar
Mitchell, S. J. et al. The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep. 6, 836–843 (2014).
Google Scholar
Zhang, N. et al. Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-κB signaling. Cell Cycle 15, 1009–1018 (2016).
Google Scholar
Benigni, A. et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J. Clin. Invest. 119, 524–530 (2009).
Google Scholar
Dai, H., Sinclair, D. A., Ellis, J. L. & Steegborn, C. Sirtuin activators and inhibitors: promises, achievements, and challenges. Pharmacol. Ther. 188, 140–154 (2018).
Google Scholar
Dang, W. The controversial world of sirtuins. Drug. Discov. Today Technol. 12, e9–e17 (2014).
Google Scholar
US National Library of Medicine. ClinicalTrials.gov (accessed 2 February 2024).
Baksi, A. et al. A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. Br. J. Clin. Pharmacol. 78, 69–77 (2014).
Google Scholar
Curry, A. M., White, D. S., Donu, D. & Cen, Y. Human sirtuin regulators: the “Success” stories. Front. Physiol. 12, 752117 (2021).
Google Scholar
Radenkovic, D. R. & Verdin, E. Clinical evidence for targeting NAD therapeutically. Pharmaceuticals 13, 247 (2020).
Google Scholar
Camacho-Pereira, J. et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 23, 1127–1139 (2016).
Google Scholar
Ugamraj, H. S. et al. TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity. mAbs 14, 2095949 (2022).
Google Scholar
Loboda, A., Sobczak, M., Jozkowicz, A. & Dulak, J. TGF-β1/Smads and miR-21 in renal fibrosis and inflammation. Mediators Inflamm. 2016, 8319283 (2016).
Google Scholar
Zhuo, L. et al. NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cell. Physiol. Biochem. 27, 681–690 (2011).
Google Scholar
Ren, Y. et al. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress. Int. J. Mol. Med. 39, 1317–1324 (2017).
Google Scholar
Mercken, E. M. et al. SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass. Aging Cell 13, 787–796 (2014).
Google Scholar
Davenport, A. M., Huber, F. M. & Hoelz, A. Structural and functional analysis of human SIRT1. J. Mol. Biol. 426, 526–541 (2014).
Google Scholar
link
